Is the Use of Dexamethasone Effective in Controlling Pain Associated with Symptomatic Irreversible Pulpitis? A Systematic Review
Journal of Endodontics
Publication History
Published online: March 20, 2018
Highlight
- •This article highlights the use of dexamethasone for controlling pain in cases of symptomatic irreversible pulpitis.
Abstract
Introduction
Endodontic
pain is a symptom of pulpal and/or periapical inflammation. One
strategy for pain reduction is using medications, such as dexamethasone.
A definitive protocol for preventing and controlling pain caused by
irreversible pulpitis during endodontic treatment has not yet been
established. This is a systematic review to answer the following
question: is the use of dexamethasone effective in controlling pain
associated with symptomatic irreversible pulpitis?
Methods
This
study was registered in the PROSPERO database (CRD42017058704), and
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
statement recommendations were followed. MEDLINE, Scopus, ScienceDirect,
Web of Science, Latin American Caribbean Health Sciences Literature,
Cochrane Library, and Google Scholar databases were used in our
research. No restrictions were applied to dates or language of
publication. All records identified electronically were organized and
evaluated by 2 independent authors, and, in case of doubt, a third
author made the decision. The Cochrane Collaboration tool was used. The
data were analyzed with RevMan 5 software (The Cochrane Collaboration,
Copenhagen, Denmark), and data from eligible studies were dichotomous
(with and without pain).
Results
A
total of 4825 studies were identified. After screening, 523 studies
were selected, and, after careful evaluation, only 5 articles remained.
All meta-analyses revealed a global effect (P < .05, P < .05, and P < .05), which means that 4 mg dexamethasone helps relieve pain, sometimes for up to 8, 12, and 24 hours.
Conclusions
The
pain felt by patients diagnosed with symptomatic irreversible pulpitis
may be alleviated by administering 4 mg dexamethasone either by mouth or
through intraligamentary and mainly supraperiosteal injections into the
root canal for up to 24 hours.
Comments